Antonio Capaldi
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
- Oncology 12
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 5
- CAR-T cell therapy research 3
- Peptidase Inhibition and Analysis 3
-
- Hematopoietic Stem Cell Transplantation 4
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Massimo Aglietta (13 shared papers)Giovannino Ciccone (3 shared papers)Mario Boccadoro (4 shared papers)Antonietta Falcone (1 shared paper)Sara Bringhen (1 shared paper)Renato Zambello (1 shared paper)Sylvain Doré (1 shared paper)Francesca Gay (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Blood (2 papers)Human Gene Therapy (1 paper)British Journal of Haematology (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- ItalyUnited StatesSweden
In The Last Decade
Antonio Capaldi
19 papers receiving 639 citations
Peers
Comparison fields: 5 of 65
- Hematology 332
- Oncology 397
- Immunology 121
- Molecular Biology 261
- Genetics 38
Countries citing papers authored by Antonio Capaldi
This map shows the geographic impact of Antonio Capaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Capaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Capaldi more than expected).
Fields of papers citing papers by Antonio Capaldi
This network shows the impact of papers produced by Antonio Capaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Capaldi. The network helps show where Antonio Capaldi may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Capaldi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 250 | |
| 2 | 2008 | 98 | |
| 3 | 1995 | 51 | |
| 4 | 2011 | 45 | |
| 5 | 2011 | 37 | |
| 6 | 2004 | 36 | |
| 7 | 2003 | 33 | |
| 8 | 2009 | 22 | |
| 9 | 2001 | 21 | |
| 10 | 2003 | 19 | |
| 11 | Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients. | 2000 | 14 |
| 12 | 2011 | 12 | |
| 13 | 2003 | 8 | |
| 14 | 2005 | 5 | |
| 15 | 2005 | 3 | |
| 16 | 1982 | 3 | |
| 17 | 2003 | 2 | |
| 18 | 2007 | 2 | |
| 19 | 2006 | 2 | |
| 20 | LIMITED GRAFT-VERSUS MYELOMA EFFECT AFTER LOW-DOSE TBI BASED NON-MYELOABLATIVE ALLOGRAFTING EMPLOYED AS SALVAGE TREATMENT COMPARED TO FIRST LINE TREATMENT | 2006 | 0 |
About Antonio Capaldi
Antonio Capaldi is a scholar working on Oncology, Hematology, Genetics, Immunology and Molecular Biology, having authored 20 papers that have together received 663 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hematology (332 citations), Oncology (397 citations), Immunology (121 citations), Molecular Biology (261 citations) and Genetics (38 citations). Antonio Capaldi has collaborated with scholars based in Italy, United States and Sweden. Frequent co-authors include Massimo Aglietta, Giovannino Ciccone, Mario Boccadoro, Antonietta Falcone, Sara Bringhen, Renato Zambello, Sylvain Doré, Francesca Gay, Anna Marina Liberati and Paolo Vineis. Their work appears in journals such as Journal of Clinical Oncology, Blood, Human Gene Therapy, British Journal of Haematology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.